Voyager Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.About VYGR
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.
CEOAlfred W. Sandrock
CEOAlfred W. Sandrock
Employees162
Employees162
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2013
Founded2013
Employees162
Employees162
VYGR Key Statistics
Market cap505.54M
Market cap505.54M
Price-Earnings ratio3.22
Price-Earnings ratio3.22
Dividend yield—
Dividend yield—
Average volume1.10M
Average volume1.10M
High today$9.68
High today$9.68
Low today$9.20
Low today$9.20
Open price$9.58
Open price$9.58
Volume443.19K
Volume443.19K
52 Week high$14.34
52 Week high$14.34
52 Week low$6.06
52 Week low$6.06
VYGR News
Yahoo Finance 2d
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c) - Yahoo FinanceVoyager Therapeutics, Inc. LEXINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to...
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%